• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by End-user o Market segments o Comparison by End-user o Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025 o Hospitals and diagnostic centers - Market size and forecast 2020-2025 o Academic institutes and research organizations - Market size and forecast 2020-2025 o Market opportunity by End-user • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Agilent Technologies Inc. o F. Hoffmann-La Roche Ltd. o Illumina Inc. o Merck KGaA o New England Biolabs Inc. o Promega Corp. o QIAGEN NV o Rockland Immunochemicals Inc. o Takara Bio Inc. o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits Exhibits1: Key Finding 1 Exhibits2: Key Finding 2 Exhibits3: Key Finding 3 Exhibits4: Key Finding 5 Exhibits5: Key Finding 6 Exhibits6: Key Finding 7 Exhibits7: Key Finding 8 Exhibits8: Parent market Exhibits9: Market characteristics Exhibits10: Offerings of vendors included in the market definition Exhibits11: Market segments Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million) Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%) Exhibits14: Five forces analysis 2020 & 2025 Exhibits15: Bargaining power of buyers Exhibits16: Bargaining power of suppliers Exhibits17: Threat of new entrants Exhibits18: Threat of substitutes Exhibits19: Threat of rivalry Exhibits20: Market condition - Five forces 2020 Exhibits21: End-user - Market share 2020-2025 (%) Exhibits22: Comparison by End-user Exhibits23: Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025 ($ million) Exhibits24: Biotechnology and pharmaceutical companies - Year-over-year growth 2020-2025 (%) Exhibits25: Hospitals and diagnostic centers - Market size and forecast 2020-2025 ($ million) Exhibits26: Hospitals and diagnostic centers - Year-over-year growth 2020-2025 (%) Exhibits27: Academic institutes and research organizations - Market size and forecast 2020-2025 ($ million) Exhibits28: Academic institutes and research organizations - Year-over-year growth 2020-2025 (%) Exhibits29: Market opportunity by End-user Exhibits30: Customer landscape Exhibits31: Market share By Geographical Landscape 2020-2025 (%) Exhibits32: Geographic comparison Exhibits33: North America - Market size and forecast 2020-2025 ($ million) Exhibits34: North America - Year-over-year growth 2020-2025 (%) Exhibits35: Europe - Market size and forecast 2020-2025 ($ million) Exhibits36: Europe - Year-over-year growth 2020-2025 (%) Exhibits37: Asia - Market size and forecast 2020-2025 ($ million) Exhibits38: Asia - Year-over-year growth 2020-2025 (%) Exhibits39: ROW - Market size and forecast 2020-2025 ($ million) Exhibits40: ROW - Year-over-year growth 2020-2025 (%) Exhibits41: Key leading countries Exhibits42: Market opportunity By Geographical Landscape ($ million) Exhibits43: Impact of drivers and challenges Exhibits44: Vendor landscape Exhibits45: Landscape disruption Exhibits46: Industry risks Exhibits47: Vendors covered Exhibits48: Market positioning of vendors Exhibits49: Agilent Technologies Inc. - Overview Exhibits50: Agilent Technologies Inc. - Business segments Exhibits51: Agilent Technologies Inc. - Key offerings Exhibits52: Agilent Technologies Inc. - Key customers Exhibits53: Agilent Technologies Inc. - Segment focus Exhibits54: F. Hoffmann-La Roche Ltd. - Overview Exhibits55: F. Hoffmann-La Roche Ltd. - Business segments Exhibits56: F. Hoffmann-La Roche Ltd. - Key offerings Exhibits57: F. Hoffmann-La Roche Ltd. - Key customers Exhibits58: F. Hoffmann-La Roche Ltd. - Segment focus Exhibits59: Illumina Inc. - Overview Exhibits60: Illumina Inc. - Product and service Exhibits61: Illumina Inc. - Key offerings Exhibits62: Illumina Inc. - Key customers Exhibits63: Illumina Inc. - Segment focus Exhibits64: Merck KGaA - Overview Exhibits65: Merck KGaA - Business segments Exhibits66: Merck KGaA - Key offerings Exhibits67: Merck KGaA - Key customers Exhibits68: Merck KGaA - Segment focus Exhibits69: New England Biolabs Inc. - Overview Exhibits70: New England Biolabs Inc. - Product and service Exhibits71: New England Biolabs Inc. - Key offerings Exhibits72: New England Biolabs Inc. - Key customers Exhibits73: New England Biolabs Inc. - Segment focus Exhibits74: Promega Corp. - Overview Exhibits75: Promega Corp. - Product and service Exhibits76: Promega Corp. - Key offerings Exhibits77: Promega Corp. - Key customers Exhibits78: Promega Corp. - Segment focus Exhibits79: QIAGEN NV - Overview Exhibits80: QIAGEN NV - Business segments Exhibits81: QIAGEN NV - Key offerings Exhibits82: QIAGEN NV - Key customers Exhibits83: QIAGEN NV - Segment focus Exhibits84: Rockland Immunochemicals Inc.- Overview Exhibits85: Rockland Immunochemicals Inc.- Product and service Exhibits86: Rockland Immunochemicals Inc.- Key offerings Exhibits87: Rockland Immunochemicals Inc.- Key customers Exhibits88: Rockland Immunochemicals Inc.- Segment focus Exhibits89: Takara Bio Inc. - Overview Exhibits90: Takara Bio Inc. - Business segments Exhibits91: Takara Bio Inc. - Key offerings Exhibits92: Takara Bio Inc. - Key customers Exhibits93: Takara Bio Inc. - Segment focus Exhibits94: Thermo Fisher Scientific Inc. - Overview Exhibits95: Thermo Fisher Scientific Inc. - Business segments Exhibits96: Thermo Fisher Scientific Inc. - Key offerings Exhibits97: Thermo Fisher Scientific Inc. - Key customers Exhibits98: Thermo Fisher Scientific Inc. - Segment focus Exhibits99: Currency conversion rates for US$ Exhibits100: Research Methodology Exhibits101: Validation techniques employed for market sizing Exhibits102: Information sources Exhibits103: List of abbreviations

Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., Thermo Fisher Scientific Inc.